Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab
Condition(s):Non-small-cell Lung Cancer PatientsLast Updated:October 5, 2022Recruiting